Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | MAP2K1 | Q02750 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14220172 | 0.93 | DHODH (0.35) | MEN1KMT2ATDP1DHODHMAP2K1 | |
| SCHEMBL14220120 | 0.90 | MAP2K1 (0.36) | MEN1KMT2ATDP1DHODHLCK | |
| SCHEMBL14219630 | 0.88 | MAP2K1 (0.40) | MEN1KMT2ATDP1DHODHLCK | |
| SCHEMBL14220178 | 0.88 | MAP2K1 (0.41) | MAP2K1ABCB11NQO2MAP2K2 | |
| SCHEMBL14219726 | 0.84 | MAP2K1 (0.34) | MEN1KMT2ATDP1DHODHMAP2K1 | |
| SCHEMBL14219684 | 0.83 | LMNA (0.42) | MEN1KMT2ADHODHLCKLMNA | |
| SCHEMBL14219727 | 0.82 | MEN1 (0.34) | MEN1KMT2ATDP1MAP2K1MAP2K2 | |
| SCHEMBL14219710 | 0.80 | MEN1 (0.40) | MEN1KMT2ATDP1DHODHMAP2K1 | |
| SCHEMBL14219711 | 0.80 | MEN1 (0.42) | MEN1KMT2ATDP1MAP2K1ABCB11 | |
| SCHEMBL14219738 | 0.80 | MEN1 (0.42) | MEN1KMT2ATDP1DHODHMAP2K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1908751-A1 | N-hydroxy benzamides with antitumour activity | EOS S.p.A. (IT) | 2008-04-09 | — | — | EP | disclosed |